These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder. Wieck A; Grassi-Oliveira R; do Prado CH; Rizzo LB; de Oliveira AS; Kommers-Molina J; Viola TW; Teixeira AL; Bauer ME Brain Behav Immun; 2013 Nov; 34():47-55. PubMed ID: 23876746 [TBL] [Abstract][Full Text] [Related]
7. Glial cells as key elements in the pathophysiology and treatment of bipolar disorder. Keshavarz M Acta Neuropsychiatr; 2017 Jun; 29(3):140-152. PubMed ID: 27772534 [TBL] [Abstract][Full Text] [Related]
8. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review. Giridharan VV; Sayana P; Pinjari OF; Ahmad N; da Rosa MI; Quevedo J; Barichello T Mol Psychiatry; 2020 Jan; 25(1):94-113. PubMed ID: 31249382 [TBL] [Abstract][Full Text] [Related]
9. The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings. Chaves-Filho A; Eyres C; Blöbaum L; Landwehr A; Tremblay MÈ J Neurochem; 2024 Sep; 168(9):1780-1816. PubMed ID: 38504593 [TBL] [Abstract][Full Text] [Related]
10. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Kim YK; Na KS; Myint AM; Leonard BE Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():277-84. PubMed ID: 26111720 [TBL] [Abstract][Full Text] [Related]
11. Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome. O'Malley D Am J Physiol Gastrointest Liver Physiol; 2016 Nov; 311(5):G934-G941. PubMed ID: 27742703 [TBL] [Abstract][Full Text] [Related]
15. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. Sayana P; Colpo GD; Simões LR; Giridharan VV; Teixeira AL; Quevedo J; Barichello T J Psychiatr Res; 2017 Sep; 92():160-182. PubMed ID: 28458141 [TBL] [Abstract][Full Text] [Related]
16. Targeting the immune system in the treatment of bipolar disorder. Rosenblat JD Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134 [TBL] [Abstract][Full Text] [Related]
17. TNF-alpha as a molecular target in bipolar disorder. Brietzke E; Kapczinski F Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1355-61. PubMed ID: 18316149 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature. Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705 [TBL] [Abstract][Full Text] [Related]
20. [The local immunoneuroendocrine system of the pancreas and the development of type-1 diabetes mellitus. A hypothesis]. Goranov VA; Murzënok PP Usp Fiziol Nauk; 1997; 28(4):105-16. PubMed ID: 9472156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]